LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | AZD 5438 | 10 | uM | LJP6 | 72 | hr | 1389 | 297 | 5445 | 0.0548 | -0.5439 |
MCF 10A | Alvocidib | 1.11 | uM | LJP6 | 72 | hr | 1694 | 299 | 11217 | 0.0267 | -0.4731 |
MCF 10A | Alvocidib | 0.37 | uM | LJP6 | 72 | hr | 1694 | 300 | 11217 | 0.0268 | -0.4707 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 765 | 300 | 3101 | 0.0968 | -0.3718 |
MCF7 | CGP60474 | 10 | uM | LJP6 | 72 | hr | 1389 | 300 | 5445 | 0.0552 | -0.5407 |
Hs 578T | Foretinib | 10 | uM | LJP5 | 72 | hr | 765 | 302 | 3148 | 0.0959 | -0.3659 |
MCF 10A | CGP60474 | 0.12 | uM | LJP6 | 72 | hr | 1694 | 306 | 11217 | 0.0273 | -0.4672 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 308 | 11217 | 0.0275 | -0.4650 |
MCF 10A | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 1694 | 309 | 11217 | 0.0276 | -0.4641 |
BT-20 | GSK1059615 | 10 | uM | LJP6 | 72 | hr | 1334 | 312 | 3925 | 0.0796 | -0.6087 |
MCF 10A | AT-7519 | 3.33 | uM | LJP6 | 72 | hr | 1694 | 314 | 11217 | 0.0280 | -0.4612 |
Hs 578T | AZD7762 | 10 | uM | LJP6 | 72 | hr | 765 | 315 | 3101 | 0.1015 | -0.3560 |
BT-20 | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1334 | 317 | 3925 | 0.0807 | -0.6034 |
Hs 578T | Fedratinib | 10 | uM | LJP5 | 72 | hr | 765 | 321 | 3148 | 0.1021 | -0.3478 |
Hs 578T | A443654 | 3.33 | uM | LJP6 | 72 | hr | 765 | 321 | 3101 | 0.1036 | -0.3494 |
Hs 578T | Withaferin A | 10 | uM | LJP5 | 72 | hr | 765 | 322 | 3148 | 0.1025 | -0.3466 |
Hs 578T | Withaferin A | 10 | uM | LJP6 | 72 | hr | 765 | 326 | 3101 | 0.1050 | -0.3465 |
BT-20 | CGP60474 | 10 | uM | LJP5 | 72 | hr | 1334 | 330 | 4033 | 0.0819 | -0.5837 |
Hs 578T | Buparlisib | 10 | uM | LJP5 | 72 | hr | 765 | 331 | 3148 | 0.1051 | -0.3367 |
MCF 10A | Alvocidib | 10 | uM | LJP6 | 72 | hr | 1694 | 336 | 11217 | 0.0299 | -0.4480 |
MCF7 | CGP60474 | 10 | uM | LJP5 | 72 | hr | 1389 | 343 | 5905 | 0.0581 | -0.4884 |
Hs 578T | Geldanamycin | 10 | uM | LJP5 | 72 | hr | 765 | 344 | 3148 | 0.1095 | -0.3253 |
MCF7 | AT-7519 | 10 | uM | LJP6 | 72 | hr | 1389 | 344 | 5445 | 0.0635 | -0.5080 |
MCF7 | Mitoxantrone | 10 | uM | LJP6 | 72 | hr | 1389 | 345 | 5445 | 0.0630 | -0.5105 |
Hs 578T | CGP60474 | 0.04 | uM | LJP6 | 72 | hr | 765 | 346 | 3101 | 0.1119 | -0.3251 |